Acetaminophen Hepatotoxicity

Nourja P, Willey M. Epidemiology of acetaminophen-related overdose. Dept of health and human services, center for drug evaluation and research, food and drug administration. FDA 2002; Available at: http://www.fda.gov/. Accessed February 26, 2007. FDA Background information for September 19–20, 2002, NDAC Meeting. FDA 2002; Available at: http://www.fda.gov/ohrms/dockets/ac/02/briefing/3882b1.htm. Accessed June 26, 2007. Thomson, 1966, Liver damage and impaired glucose tolerance after paracetamol overdosage, Br Med J, 2, 506, 10.1136/bmj.2.5512.506 Davidson, 1966, Acute liver necrosis following overdose of paracetamol, Br Med J, 2, 497 Boyd, 1966, Liver necrosis from paracetamol, Br J Pharmacol Chemother, 26, 606, 10.1111/j.1476-5381.1966.tb01841.x McJunkin, 1976, Fatal massive hepatic necrosis following acetaminophen overdose, JAMA, 236, 1874, 10.1001/jama.1976.03270170040024 NDAC meeting Sept. 19–20, 2002 transcript. FDA 2007; Available at: http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3882T1.htm. AND http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3882T2.htm. Accessed June 26, 2007. Zimmerman, 1981, Effects of aspirin and acetaminophen on the liver, Arch Intern Med, 141, 333, 10.1001/archinte.1981.00340030065013 Whitcomb, 1994, Association of acetaminophen hepatotoxicity with fasting and ethanol use, JAMA, 272, 1845, 10.1001/jama.1994.03520230055038 Slattery, 1996, The complex interaction between ethanol and acetaminophen, Clin Pharmacol Ther, 60, 241, 10.1016/S0009-9236(96)90050-8 Seeff, 1986, Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure, Ann Intern Med, 104, 399, 10.7326/0003-4819-104-3-399 Zimmerman, 1995, Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure, Hepatology, 22, 767, 10.1002/hep.1840220312 Maddrey, 1987, Hepatic effects of acetaminophen. Enhanced toxicity in alcoholics, J Clin Gastroenterol, 9, 180, 10.1097/00004836-198704000-00014 Schiodt, 1997, Acetaminophen toxicity in an urban county hospital, N Engl J Med, 337, 1112, 10.1056/NEJM199710163371602 Benson, 1983, Hepatotoxicity following the therapeutic use of antipyretic analgesics, Am J Med, 75, 85, 10.1016/0002-9343(83)90237-1 Watkins, 2006, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial, JAMA, 296, 87, 10.1001/jama.296.1.87 Kuffner, 2006, Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials, Curr Med Res Opin, 22, 2137, 10.1185/030079906X148346 FDA. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; proposed amendment of the tentative final monograph; required warnings and other labeling. 2007; Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/E6-21855.htm. Accessed June 26, 2007. Watson, 2005, 2004 annual report of the American Association of Poison Control Centers toxic exposure surveillance system, Am J Emerg Med, 23, 589, 10.1016/j.ajem.2005.05.001 Larson, 2005, Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study, Hepatology, 42, 1364, 10.1002/hep.20948 Litovitz, 1998, 1997 annual report of the American Association of Poison Control Centers toxic exposure surveillance system, Am J Emerg Med, 16, 443, 10.1016/S0735-6757(98)90000-6 Gow, 1999, Paracetamol overdose in a liver transplantation centre: an 8-year experience, J Gastroenterol Hepatol, 14, 817, 10.1046/j.1440-1746.1999.01959.x Ayonrinde, 2005, Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience, Intern Med J, 35, 655, 10.1111/j.1445-5994.2005.00947.x Park, 1995, The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity, Pharmacol Ther, 68, 385, 10.1016/0163-7258(95)02013-6 Walgren, 2005, Role of metabolism in drug-induced idiosyncratic hepatotoxicity, Crit Rev Toxicol, 35, 325, 10.1080/10408440590935620 Nelson, 2003, Mechanisms of acetaminophen-induced liver disease, 287 Graham, 2005, Tolerability of paracetamol, Drug Saf, 28, 227, 10.2165/00002018-200528030-00004 Mitchell, 1974, Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy, Clin Pharmacol Ther, 16, 676, 10.1002/cpt1974164676 Forrest, 1982, Clinical pharmacokinetics of paracetamol, Clin Pharmacokinet, 7, 93, 10.2165/00003088-198207020-00001 Manyike, 2000, Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation, Clin Pharmacol Ther, 67, 275, 10.1067/mcp.2000.104736 Watkins, 2006, Drug-induced liver injury: summary of a single topic clinical research conference, Hepatology, 43, 618, 10.1002/hep.21095 Corcoran, 1980, Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine, Mol Pharmacol, 18, 536 Thummel, 1993, Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4, Biochem Pharmacol, 45, 1563, 10.1016/0006-2952(93)90295-8 Makin, 1994, The current management of paracetamol overdosage, Br J Clin Pract, 48, 144, 10.1111/j.1742-1241.1994.tb09786.x Chen, 1998, Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6, Chem Res Toxicol, 11, 295, 10.1021/tx9701687 Sarich, 1997, The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin, Clin Pharmacol Ther, 62, 21, 10.1016/S0009-9236(97)90148-X Mitchell, 1973, Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione, J Pharmacol Exp Ther, 187, 211 Kaplowitz, 2004, Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next?, Hepatology, 40, 23, 10.1002/hep.20312 O'Brien, 1991, Formation of biological reactive intermediates by peroxidases: halide mediated acetaminophen oxidation and cytotoxicity, Adv Exp Med Biol, 283, 51, 10.1038/icb.1991.8 Potter, 1987, The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase, J Biol Chem, 262, 974, 10.1016/S0021-9258(19)75736-6 Harvison, 1988, Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase, Chem Biol Interact, 64, 251, 10.1016/0009-2797(88)90101-9 Rumack, 1975, Acetaminophen poisoning and toxicity, Pediatrics, 55, 871, 10.1542/peds.55.6.871 Eriksson, 1992, Hepatotoxicity due to repeated intake of low doses of paracetamol, J Intern Med, 231, 567, 10.1111/j.1365-2796.1992.tb00976.x Bonkovsky, 1994, Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency, Hepatology, 19, 1141, 10.1002/hep.1840190511 Moling, 2006, Severe hepatotoxicity after therapeutic doses of acetaminophen, Clin Ther, 28, 755, 10.1016/j.clinthera.2006.05.002 Bray, 1992, Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure, Hum Exp Toxicol, 11, 265, 10.1177/096032719201100405 Goldfinger, 1978, Concomitant alcohol and drug abuse enhancing acetaminophen toxicity. Report of a case, Am J Gastroenterol, 70, 385 Mutlib, 2006, Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity, Chem Res Toxicol, 19, 701, 10.1021/tx050317i Price, 1989, Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat, Biochem Pharmacol, 38, 289, 10.1016/0006-2952(89)90039-7 Chanda, 1996, Role of nutrition in the survival after hepatotoxic injury, Toxicology, 111, 163, 10.1016/0300-483X(96)03374-4 McClain, 1980, Potentiation of acetaminophen hepatotoxicity by alcohol, JAMA, 244, 251, 10.1001/jama.1980.03310030027020 Prescott, 2000, Paracetamol, alcohol and the liver, Br J Clin Pharmacol, 49, 291, 10.1046/j.1365-2125.2000.00167.x Rumack, 2002, Acetaminophen hepatotoxicity: the first 35 years, J Toxicol Clin Toxicol, 40, 3, 10.1081/CLT-120002882 Lee, 1996, Role of CYP2E1 in the hepatotoxicity of acetaminophen, J Biol Chem, 271, 12063, 10.1074/jbc.271.20.12063 Linden, 1984, Acetaminophen overdose, Emerg Med Clin North Am, 2, 103, 10.1016/S0733-8627(20)30837-3 Prescott, 1983, Paracetamol overdosage. Pharmacological considerations and clinical management, Drugs, 25, 290, 10.2165/00003495-198325030-00002 Gemborys, 1980, Mechanism of decomposition of N-hydroxyacetaminophen, a postulated toxic metabolite of acetaminophen, J Med Chem, 23, 304, 10.1021/jm00177a019 James, 2003, Acetaminophen-induced hepatotoxicity, Drug Metab Dispos, 31, 1499, 10.1124/dmd.31.12.1499 Roberts, 1987, A sensitive immunochemical assay for acetaminophen-protein adducts, J Pharmacol Exp Ther, 241, 527 Pumford, 1989, Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice, J Pharmacol Exp Ther, 248, 190 Gibson, 1996, Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress, Chem Res Toxicol, 9, 580, 10.1021/tx950153d Cohen, 1997, Selective protein arylation and acetaminophen-induced hepatotoxicity, Drug Metab Rev, 29, 59, 10.3109/03602539709037573 Pumford, 1990, Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice, Toxicol Appl Pharmacol, 104, 521, 10.1016/0041-008X(90)90174-S Roberts, 2001, Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout, 687 Harman, 1991, The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophen, Biochem Pharmacol, 41, 1111, 10.1016/0006-2952(91)90648-O Jaeschke, 2003, The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity, Toxicol Lett, 144, 279, 10.1016/S0378-4274(03)00239-X Tirmenstein, 1989, Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver, J Biol Chem, 264, 9814, 10.1016/S0021-9258(18)81731-8 Andersson, 1990, N-acetyl-p-benzoquinone imine-induced changes in the energy metabolism in hepatocytes, Chem Biol Interact, 75, 201, 10.1016/0009-2797(90)90118-7 Burcham, 1991, Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes, J Biol Chem, 266, 5049, 10.1016/S0021-9258(19)67754-9 Park, 2005, The role of metabolic activation in drug-induced hepatotoxicity, Annu Rev Pharmacol Toxicol, 45, 177, 10.1146/annurev.pharmtox.45.120403.100058 Jaeschke, 2006, Intracellular signaling mechanisms of acetaminophen-induced liver cell death, Toxicol Sci, 89, 31, 10.1093/toxsci/kfi336 Boobis, 1986, Freshly isolated hepatocytes as a model for studying the toxicity of paracetamol, Food Chem Toxicol, 24, 731, 10.1016/0278-6915(86)90172-9 Grewal, 1993, Intracellular calcium disruption as a secondary event in acetaminophen-induced hepatotoxicity, Can J Physiol Pharmacol, 71, 26, 10.1139/y93-004 Blazka, 1995, Role of proinflammatory cytokines in acetaminophen hepatotoxicity, Toxicol Appl Pharmacol, 133, 43, 10.1006/taap.1995.1125 Liu, 2004, Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity, Gastroenterology, 127, 1760, 10.1053/j.gastro.2004.08.053 Liu, 2006, Role of innate immunity in acetaminophen-induced hepatotoxicity, Expert Opin Drug Metab Toxicol, 2, 493, 10.1517/17425255.2.4.493 Ishida, 2002, A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury, FASEB J, 16, 1227, 10.1096/fj.02-0046com Cover, 2006, Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity, Toxicol Appl Pharmacol, 216, 98, 10.1016/j.taap.2006.04.010 Jaeschke, 2006, How relevant are neutrophils for acetaminophen hepatotoxicity?, Hepatology, 43, 1191, 10.1002/hep.21246 Hinson, 2004, Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition, Drug Metab Rev, 36, 805, 10.1081/DMR-200033494 Miller, 1976, Acetaminophen elimination kinetics in neonates, children, and adults, Clin Pharmacol Ther, 19, 284, 10.1002/cpt1976193284 van der Marel, 2003, Paracetamol and metabolite pharmacokinetics in infants, Eur J Clin Pharmacol, 59, 243, 10.1007/s00228-003-0608-0 Peterson, 1981, Age as a variable in acetaminophen overdose, Arch Intern Med, 141, 390, 10.1001/archinte.1981.00340030122022 Rumack, 1986, Acetaminophen overdose in children and adolescents, Pediatr Clin North Am, 33, 691, 10.1016/S0031-3955(16)36050-3 Rivera-Penera, 1997, Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity, J Pediatr, 130, 300, 10.1016/S0022-3476(97)70359-7 Nelson, 1990, Molecular mechanisms of the hepatotoxicity caused by acetaminophen, Semin Liver Dis, 10, 267, 10.1055/s-2008-1040482 Rumore, 1992, Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity, J Pharm Sci, 81, 203, 10.1002/jps.2600810302 Tarloff, 1996, Sex- and age-dependent acetaminophen hepato- and nephrotoxicity in Sprague-Dawley rats: role of tissue accumulation, nonprotein sulfhydryl depletion, and covalent binding, Fundam Appl Toxicol, 30, 13, 10.1006/faat.1996.0038 Alander, 2000, Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury, Arch Pediatr Adolesc Med, 154, 346, 10.1001/archpedi.154.4.346 Ueshima, 1996, Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes, Alcohol Clin Exp Res, 20, 25A, 10.1111/j.1530-0277.1996.tb01722.x Benson, 2005, The therapeutic use of acetaminophen in patients with liver disease, Am J Ther, 12, 133, 10.1097/01.mjt.0000140216.40700.95 Farrell, 1979, Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes, Clin Pharmacol Ther, 26, 483, 10.1002/cpt1979264483 Guengerich, 1991, Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples, J Pharmacol Exp Ther, 256, 1189 Rumack, 2004, Acetaminophen misconceptions, Hepatology, 40, 10, 10.1002/hep.20300 Lee, 2004, Acetaminophen and the U.S. Acute Liver Failure study group: lowering the risks of hepatic failure, Hepatology, 40, 6, 10.1002/hep.20293 Rumack, 1981, Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment, Arch Intern Med, 141, 380, 10.1001/archinte.1981.00340030112020 Altomare, 1984, Interaction of acute ethanol administration with acetaminophen metabolism and toxicity in rats fed alcohol chronically, Alcohol Clin Exp Res, 8, 405, 10.1111/j.1530-0277.1984.tb05688.x Thummel, 1988, Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen, J Pharmacol Exp Ther, 245, 129 Thummel, 1989, Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes, Toxicol Appl Pharmacol, 100, 391, 10.1016/0041-008X(89)90287-1 Schmidt, 2002, Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity, Hepatology, 35, 876, 10.1053/jhep.2002.32148 Schiodt, 2002, Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose, Aliment Pharmacol Ther, 16, 707, 10.1046/j.1365-2036.2002.01224.x Black, 1986, Acetaminophen, alcohol, and cytochrome P-450, Ann Intern Med, 104, 427, 10.7326/0003-4819-104-3-427 Perrot, 1989, Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake, Eur J Clin Invest, 19, 549, 10.1111/j.1365-2362.1989.tb00273.x Lucas, 1995, Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase, Alcohol Clin Exp Res, 19, 362, 10.1111/j.1530-0277.1995.tb01516.x Lauterburg, 1988, Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity, Gut, 29, 1153, 10.1136/gut.29.9.1153 Lieber, 1993, Biochemical factors in alcoholic liver disease, Semin Liver Dis, 13, 136, 10.1055/s-2007-1007345 Newman, 1979, Acetaminophen hepatotoxicity and malnutrition, Am J Gastroenterol, 72, 647 Cheung, 1994, Acetaminophen treatment nomogram, N Engl J Med, 330, 1907, 10.1056/NEJM199406303302619 Makin, 1995, A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993), Gastroenterology, 109, 1907, 10.1016/0016-5085(95)90758-0 Bizovi, 2002, Acetaminophen, 480 Makin, 2000, Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose, QJM, 93, 341, 10.1093/qjmed/93.6.341 Kuffner, 2001, Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial, Arch Intern Med, 161, 2247, 10.1001/archinte.161.18.2247 FDA. Alcohol warnings for pain relievers and fever reducers. 1998; Available at: http://www.fda.gov/bbs/topics/NEWS/NEW00659.html. Accessed March 1, 2007. Toes, 2005, Drug interactions with paracetamol, Am J Ther, 12, 56, 10.1097/00045391-200501000-00009 Nolan, 1994, Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis, Chest, 105, 408, 10.1378/chest.105.2.408 Nicod, 1997, Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells, Hum Exp Toxicol, 16, 28, 10.1177/0960327197016001061 Moulding, 1991, Acetaminophen, isoniazid, and hepatic toxicity, Ann Intern Med, 114, 431, 10.7326/0003-4819-114-5-431_2 Minton, 1988, Fatal paracetamol poisoning in an epileptic, Hum Toxicol, 7, 33, 10.1177/096032718800700106 McClements, 1990, Management of paracetamol poisoning complicated by enzyme induction due to alcohol or drugs, Lancet, 335, 1526, 10.1016/0140-6736(90)93063-U Suchin, 2005, Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantation, Dig Dis Sci, 50, 1836, 10.1007/s10620-005-2947-4 Kostrubsky, 2005, Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes, Toxicol Sci, 87, 146, 10.1093/toxsci/kfi211 Shriner, 1992, Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine, Am J Med, 93, 94, 10.1016/0002-9343(92)90687-7 Levine, 1995, Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex, Drug Metab Dispos, 23, 1407 Slattery, 1989, Lack of effect of cimetidine on acetaminophen disposition in humans, Clin Pharmacol Ther, 46, 591, 10.1038/clpt.1989.190 Burkhart, 1995, Cimetidine as adjunctive treatment for acetaminophen overdose, Hum Exp Toxicol, 14, 299, 10.1177/096032719501400311 Estes, 2003, High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure, Arch Surg, 138, 852, 10.1001/archsurg.138.8.852 Price, 1987, Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat, Biochem Pharmacol, 36, 427, 10.1016/0006-2952(87)90346-7 Kurtovic, 2003, Paracetamol-induced hepatotoxicity at recommended dosage, J Intern Med, 253, 240, 10.1046/j.1365-2796.2003.01097.x Ito, 2006, Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice, Microcirculation, 13, 19, 10.1080/10739680500383423 Lauterburg, 2002, Analgesics and glutathione, Am J Ther, 9, 225, 10.1097/00045391-200205000-00008 Dong, 1998, Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects, Ther Drug Monit, 20, 371, 10.1097/00007691-199808000-00002 Seo, 2000, Effects of benzothiazole on the xenobiotic metabolizing enzymes and metabolism of acetaminophen, J Appl Toxicol, 20, 427, 10.1002/1099-1263(200011/12)20:6<427::AID-JAT707>3.0.CO;2-# MacLeod, 2000, Cancer therapy and polymorphisms of cytochromes P450, Clin Chem Lab Med, 38, 883, 10.1515/CCLM.2000.128 Schmidt, 2003, The impact of current tobacco use on the outcome of paracetamol poisoning, Aliment Pharmacol Ther, 18, 979, 10.1046/j.1365-2036.2003.01789.x Bromer, 2003, Acetaminophen hepatotoxicity, Clin Liver Dis, 7, 351, 10.1016/S1089-3261(03)00025-4 Strubelt, 1979, Studies on the mechanism of paracetamol-induced protection against paracetamol hepatotoxicity, Toxicology, 12, 121, 10.1016/0300-483X(79)90038-6 Poulsen, 1988, Long-term administration of toxic doses of paracetamol (acetaminophen) to rats, Liver, 8, 151, 10.1111/j.1600-0676.1988.tb00984.x Shayiq, 1999, Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury, Hepatology, 29, 451, 10.1002/hep.510290241 Jones, 1993, Paracetamol poisoning and the kidney, J Clin Pharm Ther, 18, 5, 10.1111/j.1365-2710.1993.tb00560.x Singer, 1995, The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction, Ann Emerg Med, 26, 49, 10.1016/S0196-0644(95)70237-7 Bessems, 2001, Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches, Crit Rev Toxicol, 31, 55, 10.1080/20014091111677 Curry, 1982, Acute renal failure after acetaminophen ingestion, JAMA, 247, 1012, 10.1001/jama.1982.03320320048029 von Mach, 2005, Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 cases, Clin Toxicol (Phila), 43, 31, 10.1081/CLT-44992 Mour, 2005, Acute renal dysfunction in acetaminophen poisoning, Ren Fail, 27, 381, 10.1081/JDI-200065428 Mofenson, 1991, Acetaminophen induced pancreatitis, J Toxicol Clin Toxicol, 29, 223, 10.3109/15563659109038615 Record, 1975, Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose, Clin Sci Mol Med, 49, 473 Heinig, 1979, Lactic acidosis and liver disease, Arch Intern Med, 139, 1229, 10.1001/archinte.1979.03630480019010 Bihari, 1985, Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis, J Hepatol, 1, 405, 10.1016/S0168-8278(85)80778-9 Bernal, 1998, Use and outcome of liver transplantation in acetaminophen-induced acute liver failure, Hepatology, 27, 1050, 10.1002/hep.510270421 Harrison, 1990, Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure, BMJ, 301, 964, 10.1136/bmj.301.6758.964 Tsutsumi, 1989, The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver, Hepatology, 10, 437, 10.1002/hep.1840100407 Baeg, 1988, Long-term sequelae of acetaminophen-associated fulminant hepatic failure: relevance of early histology, Am J Gastroenterol, 83, 569 Bertholf, 2003, False-positive acetaminophen results in a hyperbilirubinemic patient, Clin Chem, 49, 695, 10.1373/49.4.695 Polson, 2004, Elevated bilirubin may cause false positive acetaminophen levels in hepatitis patients, Hepatology, 40, 496A Beuhler, 2005, False positive acetaminophen levels associated with hyperbilirubinemia, Clin Toxicol (Phila), 43, 167, 10.1081/CLT-200057853 Muldrew, 2002, Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection, Drug Metab Dispos, 30, 446, 10.1124/dmd.30.4.446 Davern, 2006, Measurement of serum acetaminophen-protein adducts in patients with acute liver failure, Gastroenterology, 130, 687, 10.1053/j.gastro.2006.01.033 Read, 1986, Analysis of factors responsible for continuing mortality after paracetamol overdose, Hum Toxicol, 5, 201, 10.1177/096032718600500309 Ambre, 1977, Liver toxicity after acetaminophen ingestion. Inadequacy of the dose estimate as an index of risk, JAMA, 238, 500, 10.1001/jama.1977.03280060044019 Smilkstein, 1988, Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985), N Engl J Med, 319, 1557, 10.1056/NEJM198812153192401 Reid, 2003, Paracetamol poisoning: which nomogram should we use?, Emerg Med (Fremantle), 15, 486, 10.1046/j.1442-2026.2003.00507.x Tan, 2006, Comparative pharmacokinetics of Panadol extend and immediate-release paracetamol in a simulated overdose model, Emerg Med Australas, 18, 398, 10.1111/j.1742-6723.2006.00873.x Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 Daly, 2004, Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion, Ann Emerg Med, 44, 393, 10.1016/j.annemergmed.2004.05.005 Sivilotti, 2005, A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine, Ann Emerg Med, 46, 263, 10.1016/j.annemergmed.2005.04.004 Prescott, 1979, Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning, Br Med J, 2, 1097, 10.1136/bmj.2.6198.1097 Prescott, 1980, Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning, Br Med J, 280, 46, 10.1136/bmj.280.6206.46-b Kerr, 2005, The Australasian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine, Ann Emerg Med, 45, 402, 10.1016/j.annemergmed.2004.08.040 Bond, 1993, Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population, Ann Emerg Med, 22, 1403, 10.1016/S0196-0644(05)81986-9 Underhill, 1990, A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose, Arch Emerg Med, 7, 148, 10.1136/emj.7.3.148 Rose, 1991, Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal, Ann Emerg Med, 20, 1064, 10.1016/S0196-0644(05)81353-8 Spiller, 1994, A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose, Ann Emerg Med, 23, 519, 10.1016/S0196-0644(94)70071-0 Prescott, 1977, Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine, Lancet, 2, 432, 10.1016/S0140-6736(77)90612-2 Peterson, 1977, Treating acute acetaminophen poisoning with acetylcysteine, JAMA, 237, 2406, 10.1001/jama.1977.03270490046025 Buckpitt, 1979, Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation, Biochem Pharmacol, 28, 2941, 10.1016/0006-2952(79)90590-2 Lin, 1981, Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats, Biochem Pharmacol, 30, 2723, 10.1016/0006-2952(81)90547-5 Miners, 1984, Mechanism of action of paracetamol protective agents in mice in vivo, Biochem Pharmacol, 33, 2995, 10.1016/0006-2952(84)90599-9 Corcoran, 1985, Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice, J Pharmacol Exp Ther, 232, 857 Slattery, 1987, Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans, Clin Pharmacol Ther, 41, 413, 10.1038/clpt.1987.50 Harrison, 1990, Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine, Lancet, 335, 1572, 10.1016/0140-6736(90)91388-Q Harrison, 1991, Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure, N Engl J Med, 324, 1852, 10.1056/NEJM199106273242604 Keays, 1991, Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial, BMJ, 303, 1026, 10.1136/bmj.303.6809.1026 Jones, 1998, Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review, J Toxicol Clin Toxicol, 36, 277, 10.3109/15563659809028022 Burns MJ, Friedman SL, Larson AM. Acetaminophen (paracetamol) intoxication in adults. In: Rose BD, editor. UpToDate. Available at: http://www.uptodate.com. Accessed June 26, 2007. Woo, 2000, Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose, Ann Emerg Med, 35, 363, 10.1016/S0196-0644(00)70055-2 Tsai, 2005, A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication, Clin Ther, 27, 336, 10.1016/j.clinthera.2005.03.002 Yip, 1998, Intravenous administration of oral N-acetylcysteine, Crit Care Med, 26, 40, 10.1097/00003246-199801000-00014 Betten, 2007, A prospective evaluation of shortened course oral N-acetylcysteine for the treatment of acute acetaminophen poisoning, Ann Emerg Med, 10.1016/j.annemergmed.2006.11.010 Bronstein, 1985, Intravenous N-acetylcysteine for acute acetaminophen poisoning, Vet Hum Toxicol, 27, 316 Holdiness, 1991, Clinical pharmacokinetics of N-acetylcysteine, Clin Pharmacokinet, 20, 123, 10.2165/00003088-199120020-00004 Selden, 1991, Transplacental transport of N-acetylcysteine in an ovine model, Ann Emerg Med, 20, 1069, 10.1016/S0196-0644(05)81354-X Smilkstein, 1991, Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol, Ann Emerg Med, 20, 1058, 10.1016/S0196-0644(05)81352-6 Kociancic, 2003, Acetaminophen intoxication and length of treatment: how long is long enough?, Pharmacotherapy, 23, 1052, 10.1592/phco.23.8.1052.32884 Perry, 1998, Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial, J Pediatr, 132, 149, 10.1016/S0022-3476(98)70501-3 Ho, 1983, Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases, Br Med J (Clin Res Ed), 287, 876, 10.1136/bmj.287.6396.876 Mant, 1984, Adverse reactions to acetylcysteine and effects of overdose, Br Med J (Clin Res Ed), 289, 217, 10.1136/bmj.289.6439.217 Dawson, 1989, Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning, Med J Aust, 150, 329, 10.5694/j.1326-5377.1989.tb136496.x Flanagan, 1991, Use of N-acetylcysteine in clinical toxicology, Am J Med, 91, 131S, 10.1016/0002-9343(91)90296-A Vale, 1995, Paracetamol (acetaminophen) poisoning, Lancet, 346, 547, 10.1016/S0140-6736(95)91385-8 Bailey, 1998, Management of anaphylactoid reactions to intravenous N-acetylcysteine, Ann Emerg Med, 31, 710, 10.1016/S0196-0644(98)70229-X Dean, 1996, Outpatient N-acetylcysteine treatment for acetaminophen poisoning: an ethical dilemma or a new financial mandate?, Vet Hum Toxicol, 38, 222 Piperno, 1976, Reversal of experimental paracetamol toxicosis with N-acetylcysteine, Lancet, 2, 738, 10.1016/S0140-6736(76)90030-1 O'Grady, 1989, Early indicators of prognosis in fulminant hepatic failure, Gastroenterology, 97, 439, 10.1016/0016-5085(89)90081-4 O'Grady, 1986, Coagulopathy of fulminant hepatic failure, Semin Liver Dis, 6, 159, 10.1055/s-2008-1040599 Munoz, 1991, Prothrombin time in fulminant hepatic failure, Gastroenterology, 100, 1480, 10.1016/S0016-5085(16)34599-1 Izumi, 1996, Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure, Hepatology, 23, 1507, 10.1002/hep.510230630 Pereira, 1992, Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators, Gut, 33, 98, 10.1136/gut.33.1.98